Voluntarily Files for Chapter 11 Restructuring Strategic Alternatives Process Continues with Interest from Parties Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a...
-- Preliminary randomized Phase 2 data suggest GRANITE (personalized neoantigen vaccine) could drive meaningful clinical benefit in front-line metastatic microsatellite-stable colorectal cancer...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
4 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
12 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
26 | -0.6278 | -95.1212121212 | 0.66 | 0.68 | 0.031 | 8468263 | 0.08837322 | CS |
52 | -2.7078 | -98.8248175182 | 2.74 | 3.1 | 0.031 | 5373733 | 0.35189331 | CS |
156 | -4.9578 | -99.3547094188 | 4.99 | 6.1 | 0.031 | 2614992 | 1.10173937 | CS |
260 | -9.4078 | -99.6588983051 | 9.44 | 34.67 | 0.031 | 1987762 | 3.64462844 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約